beta-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis

Ling Fu1, Kazumasa Isobe, Qin Zeng

  • 1Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.

Insights

Beta-adrenoceptor activation downregulates adiponectin and upregulates TNF-alpha, potentially contributing to insulin resistance. Upregulation of adiponectin receptor 2 may be a feedback response to reduced adiponectin levels.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Adipose Tissue Biology

Background:

  • Adiponectin enhances insulin sensitivity, while TNF-alpha promotes insulin resistance.
  • Previous studies suggest mutual inhibition of adiponectin and TNF-alpha production in adipocytes.
  • Beta(3)-adrenoceptor agonists are investigated for their metabolic effects.

Purpose of the Study:

  • To investigate the effects of beta(3)-adrenoceptor agonists (CL-316,243 and BRL37344) on adiponectin, TNF-alpha, and their receptor gene expression in mouse adipose tissues.
  • To explore the impact of beta-adrenoceptor activation on adiponectin and TNF-alpha in 3T3-L1 adipocytes.

Main Methods:

  • Administration of beta(3)-adrenoceptor agonists CL-316,243 and BRL37344 to C57BL/6J mice.
  • Gene expression analysis of adiponectin, adiponectin receptors (1 and 2), and TNF-alpha in various adipose tissues.
  • Treatment of differentiated 3T3-L1 adipocytes with isoproterenol (a non-selective beta-adrenoceptor agonist).
  • Measurement of TNF-alpha protein expression and adiponectin secretion in treated adipocytes.

Main Results:

  • CL-316,243 and BRL37344 downregulated adiponectin and upregulated adiponectin receptor 2 (not receptor 1) in white and brown adipose tissues.
  • TNF-alpha expression was upregulated in epididymal adipose tissue following agonist treatment.
  • In 3T3-L1 adipocytes, isoproterenol decreased adiponectin expression/secretion but increased adiponectin receptor 2 and TNF-alpha protein expression.
  • Signaling pathways involving adenylyl cyclase, PKA, and AMPK were implicated in the observed effects.

Conclusions:

  • Beta-adrenoceptor activation leads to decreased adiponectin and increased TNF-alpha, potentially contributing to catecholamine-induced insulin resistance.
  • Upregulation of adiponectin receptor 2 appears to be a compensatory response to reduced adiponectin levels.
  • These findings highlight a complex interplay between beta-adrenergic signaling, adipokines, and insulin resistance.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...